Nelson Advisors thought leadership has been referenced in the Forbes article '5 High-Growth Business Models Set To Thrive In The Coming Decade' outlining five business models that are primed for success in the coming years.

The intersection between defense innovation and medical technology (MedTech) represents a fundamental structural shift, moving beyond simple technological spillovers to establish a mutually reinforcing economic and R&D ecosystem. Military Research and Development (R&D) functions as a highly accelerated, high-stakes validation engine, forcing the creation of exceptionally robust, autonomous, and efficient medical capabilities required for assured care in austere and contested

The global sleep technology sector is poised for a significant strategic inflection point by 2026, driven by the convergence of advanced consumer hardware and clinically validated digital therapeutics. Market forecasts confirm a robust growth trajectory, positioning the sector to move decisively beyond generalised wellness tracking into the regulated realm of personalised health intervention. The global Sleep Tech Devices market is projected to reach approximately USD $30.74

The global financial system is currently operating under a pervasive and quantifiable risk of a sharp market correction, a hazard explicitly documented by the Bank of England's (BoE) Financial Policy Committee (FPC) in its October 2025 update. The core driver of this instability is the hyper-concentration and seemingly limitless valuation of assets tethered to Artificial Intelligence (AI) technology. The FPC has raised a clear warning regarding the growing risk that tech stoc

Nelson Advisors is positioned as a highly specialised M&A advisory firm with an exclusive dedication to the dynamic European healthcare technology (HealthTech) sector, with advisory reach across the UK and North America. This focused dedication forms the bedrock of their value proposition, enabling a nuanced understanding of the technological advancements and market dynamics that are critical for successful transactions within this complex industry.

Nelson Advisors has been invited to join the 'Startups and Corporates: How to Build Meaningful Partnerships in MedTech' panel at MedTech Europe 2025. Nelson Advisors Partner Lloyd Price will join fellow panellists including..

The Healthtech industry operates at the critical confluence of rapid technological velocity and necessary regulatory gravity. This dynamic tension, exemplified by the swift advancement of digital innovation (e.g., AI/ML) encountering historically complex and risk-averse regulatory frameworks (such as HIPAA and FDA oversight), demands an organisational philosophy built not on rigidity, but on adaptive strength. The Bamboo Mindset, defined by its core pillars of Flexibility, Re

The major stories in the world of European MedTech this week are dominated by regulatory activity under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), a significant European Commission "Call for Evidence" for future reforms, and fresh funding for companies focused on connected and remote monitoring devices.

The convergence of a disciplined financial market, heightened buyer demands for measurable ROI, and regulatory mandates for digital interoperability creates three dominant strategic pressures for HealthTech as we look ahead into 2026: Disintermediation, Differentiation and Diversification.

The European HealthTech ecosystem is undergoing an accelerated Strategic Maturation Stress Test.This phase is characterised by intense, localised friction points, acute clinical fatigue among providers stemming from friction-laden Electronic Health Record (EHR) systems and operational pressure on developers navigating regulatory complexity. Crucially, these pressures are not causing widespread collapse but are acting as powerful catalysts, enforcing market cleanup and consoli

The advisory landscape supporting Mergers and Acquisitions (M&A) within the European Digital Health sector is highly structured and complex, reflecting both the rapid technological evolution of the industry and the strategic consolidation imperatives driving its participants. A comprehensive analysis demonstrates that a singular definition of a "leading" advisor is insufficient. Instead, the market is fundamentally characterised by a bimodal distribution of influence.

Nelson Advisors have accepted an invitation to present to the Healthcare Club at the IESE Business School, Barcelona in December 2025. The Founding Partners of Nelson Advisors believe strongly in sharing their experiences and knowledge of the HealthTech and MedTech markets with students across a wide range of UK and European Universities ranging from Oxford University and University of Cambridge to London Business School and University College London Global Business Schood fo

Nelson Advisors Partner Lloyd Price has been invited to Judge the PitchFest Awards at ReWired 2026. This is the 3rd time Lloyd has Judged the prestigious awards, highlighting the pedigree of UK Digital Health and MedTech companies.

The Microsoft Research paper, "The Illusion of Readiness: Stress Testing Large Frontier Models on Multimodal Medical Benchmarks", delivers a strategic and technical indictment of the current methodology used to evaluate Large Frontier Models (LFMs) in healthcare. The central conclusion is that high scores achieved by leading systems, such as GPT-5, on static medical benchmarks cultivate a misleading "illusion of readiness" for high-stakes clinical deployment.

The European Union Data Act (Regulation (EU) 2023/2854) represents a paradigm shift in the governance of machine-generated data within the European data economy. As a central pillar of the EU’s Digital Decade objectives, the Data Act’s primary goal is to foster competition and innovation by mitigating technical and contractual lock-ins that historically granted manufacturers exclusive control over the data generated by connected products. This mandate has profound implication